Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$5.58 - $8.61 $13,899 - $21,447
2,491 Added 3.58%
72,030 $469,000
Q1 2024

Apr 16, 2024

BUY
$8.32 - $15.45 $6,606 - $12,267
794 Added 1.15%
69,539 $605,000
Q4 2023

Feb 05, 2024

BUY
$8.79 - $11.51 $8,614 - $11,279
980 Added 1.45%
68,745 $786,000
Q3 2023

Oct 13, 2023

BUY
$8.25 - $11.35 $559,061 - $769,132
67,765 New
67,765 $652,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $616M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.